Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities

M. C. Palanca-Wessels, Michael Barrett, P. C. Galipeau, K. L. Rohrer, B. J. Reid, P. S. Rabinovitch

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Background and Aims: Progression to cancer in Barrett's esophagus occurs through an accumulation of cell cycle and genetic abnormalities that have been documented in vivo. To better study neoplastic evolution in Barrett's esophagus, the aim of this study was to establish in vitro cultures from preneoplastic tissues. Methods: Mechanical and enzymatic dissociation methods were used to initiate Barrett's epithelial cultures from endoscopic biopsy specimens, and the cells were characterized using flow-cytometric, cytogenetic, and molecular genetic analyses. Results: Four long-term cultures were established from 39 attempts. All cultures contain cytogenetic abnormalities and elevated flow-cytometric 4N DNA content fractions. Molecular genetic abnormalities detected include the following: 9p and/or CDKN2/p16 abnormalities in 4 of 4 cultures, 17p loss of heterozygosity and p53 mutation in 3 of 4 cultures, and 5q loss of heterozygosity in 1 of 4 cultures. Inactivation of p53 was statistically associated with successful long-term culture. Conclusions: These cultures contain cell cycle and molecular genetic abnormalities that closely parallel those previously documented to occur early in cancer development in Barrett's esophagus in vivo. These alterations also appear to be associated with successful growth in vitro. The cultures may provide a premalignant in vitro system in which to test potential therapies for Barrett's esophagus as well as to examine etiologic factors and genetic intermediates important in neoplastic progression.

Original languageEnglish (US)
Pages (from-to)295-304
Number of pages10
JournalGastroenterology
Volume114
Issue number2
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Barrett Esophagus
Ploidies
Chromosome Aberrations
Molecular Biology
Loss of Heterozygosity
Cell Cycle
Cytogenetics
Neoplasms
Biopsy
Mutation
DNA
Growth
In Vitro Techniques
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. / Palanca-Wessels, M. C.; Barrett, Michael; Galipeau, P. C.; Rohrer, K. L.; Reid, B. J.; Rabinovitch, P. S.

In: Gastroenterology, Vol. 114, No. 2, 1998, p. 295-304.

Research output: Contribution to journalArticle

Palanca-Wessels, M. C. ; Barrett, Michael ; Galipeau, P. C. ; Rohrer, K. L. ; Reid, B. J. ; Rabinovitch, P. S. / Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. In: Gastroenterology. 1998 ; Vol. 114, No. 2. pp. 295-304.
@article{5a5652bcc1084915b438a3fa529d0175,
title = "Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities",
abstract = "Background and Aims: Progression to cancer in Barrett's esophagus occurs through an accumulation of cell cycle and genetic abnormalities that have been documented in vivo. To better study neoplastic evolution in Barrett's esophagus, the aim of this study was to establish in vitro cultures from preneoplastic tissues. Methods: Mechanical and enzymatic dissociation methods were used to initiate Barrett's epithelial cultures from endoscopic biopsy specimens, and the cells were characterized using flow-cytometric, cytogenetic, and molecular genetic analyses. Results: Four long-term cultures were established from 39 attempts. All cultures contain cytogenetic abnormalities and elevated flow-cytometric 4N DNA content fractions. Molecular genetic abnormalities detected include the following: 9p and/or CDKN2/p16 abnormalities in 4 of 4 cultures, 17p loss of heterozygosity and p53 mutation in 3 of 4 cultures, and 5q loss of heterozygosity in 1 of 4 cultures. Inactivation of p53 was statistically associated with successful long-term culture. Conclusions: These cultures contain cell cycle and molecular genetic abnormalities that closely parallel those previously documented to occur early in cancer development in Barrett's esophagus in vivo. These alterations also appear to be associated with successful growth in vitro. The cultures may provide a premalignant in vitro system in which to test potential therapies for Barrett's esophagus as well as to examine etiologic factors and genetic intermediates important in neoplastic progression.",
author = "Palanca-Wessels, {M. C.} and Michael Barrett and Galipeau, {P. C.} and Rohrer, {K. L.} and Reid, {B. J.} and Rabinovitch, {P. S.}",
year = "1998",
doi = "10.1016/S0016-5085(98)70480-9",
language = "English (US)",
volume = "114",
pages = "295--304",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities

AU - Palanca-Wessels, M. C.

AU - Barrett, Michael

AU - Galipeau, P. C.

AU - Rohrer, K. L.

AU - Reid, B. J.

AU - Rabinovitch, P. S.

PY - 1998

Y1 - 1998

N2 - Background and Aims: Progression to cancer in Barrett's esophagus occurs through an accumulation of cell cycle and genetic abnormalities that have been documented in vivo. To better study neoplastic evolution in Barrett's esophagus, the aim of this study was to establish in vitro cultures from preneoplastic tissues. Methods: Mechanical and enzymatic dissociation methods were used to initiate Barrett's epithelial cultures from endoscopic biopsy specimens, and the cells were characterized using flow-cytometric, cytogenetic, and molecular genetic analyses. Results: Four long-term cultures were established from 39 attempts. All cultures contain cytogenetic abnormalities and elevated flow-cytometric 4N DNA content fractions. Molecular genetic abnormalities detected include the following: 9p and/or CDKN2/p16 abnormalities in 4 of 4 cultures, 17p loss of heterozygosity and p53 mutation in 3 of 4 cultures, and 5q loss of heterozygosity in 1 of 4 cultures. Inactivation of p53 was statistically associated with successful long-term culture. Conclusions: These cultures contain cell cycle and molecular genetic abnormalities that closely parallel those previously documented to occur early in cancer development in Barrett's esophagus in vivo. These alterations also appear to be associated with successful growth in vitro. The cultures may provide a premalignant in vitro system in which to test potential therapies for Barrett's esophagus as well as to examine etiologic factors and genetic intermediates important in neoplastic progression.

AB - Background and Aims: Progression to cancer in Barrett's esophagus occurs through an accumulation of cell cycle and genetic abnormalities that have been documented in vivo. To better study neoplastic evolution in Barrett's esophagus, the aim of this study was to establish in vitro cultures from preneoplastic tissues. Methods: Mechanical and enzymatic dissociation methods were used to initiate Barrett's epithelial cultures from endoscopic biopsy specimens, and the cells were characterized using flow-cytometric, cytogenetic, and molecular genetic analyses. Results: Four long-term cultures were established from 39 attempts. All cultures contain cytogenetic abnormalities and elevated flow-cytometric 4N DNA content fractions. Molecular genetic abnormalities detected include the following: 9p and/or CDKN2/p16 abnormalities in 4 of 4 cultures, 17p loss of heterozygosity and p53 mutation in 3 of 4 cultures, and 5q loss of heterozygosity in 1 of 4 cultures. Inactivation of p53 was statistically associated with successful long-term culture. Conclusions: These cultures contain cell cycle and molecular genetic abnormalities that closely parallel those previously documented to occur early in cancer development in Barrett's esophagus in vivo. These alterations also appear to be associated with successful growth in vitro. The cultures may provide a premalignant in vitro system in which to test potential therapies for Barrett's esophagus as well as to examine etiologic factors and genetic intermediates important in neoplastic progression.

UR - http://www.scopus.com/inward/record.url?scp=0031940211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031940211&partnerID=8YFLogxK

U2 - 10.1016/S0016-5085(98)70480-9

DO - 10.1016/S0016-5085(98)70480-9

M3 - Article

VL - 114

SP - 295

EP - 304

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -